BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27557490)

  • 21. Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma.
    Wang JH; Huang ST; Zhang L; Liu ZG; Liang RX; Jiang SW; Jiang YN; Yu XJ; Jiang YC; Li XZ; Zhang PF; Wen ZS; Zheng M
    Cancer Med; 2019 Mar; 8(3):1315-1325. PubMed ID: 30741466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
    Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
    Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
    Zhang JM; Wei K; Jiang M
    Breast Cancer; 2018 Jul; 25(4):447-455. PubMed ID: 29536377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    Kim TM; Ko YH; Ha SJ; Lee HH
    BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.
    Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S
    Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
    Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
    Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.
    Guerra-Rebollo M; Garrido C; Sánchez-Cid L; Soler-Botija C; Meca-Cortés O; Rubio N; Blanco J
    Sci Rep; 2019 Jul; 9(1):9549. PubMed ID: 31267022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1.
    Ma Y; Yan F; Wei W; Deng J; Li L; Liu L; Sun J
    Cell Cycle; 2019 Oct; 18(20):2757-2769. PubMed ID: 31438772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
    Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
    World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas.
    Sedaghat S; Gheytanchi E; Asgari M; Roudi R; Keymoosi H; Madjd Z
    Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):196-202. PubMed ID: 26945449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model.
    Anfuso B; El-Khobar KE; Ie SI; Avellini C; Radillo O; Raseni A; Tiribelli C; Sukowati CHC
    Sci Rep; 2018 Sep; 8(1):13168. PubMed ID: 30177788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
    Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
    J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
    Basati G; Mohammadpour H; Emami Razavi A
    J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of CD133, histone deacetylase 1 and thrombospondin-1 in gastric cancer.
    Eto S; Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nakao T; Nishi M; Takasu C; Sato H; Kurita N
    Anticancer Res; 2015 Apr; 35(4):2071-6. PubMed ID: 25862862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
    Yang L; Xu JF; Kang Q; Li AQ; Jin P; Wang X; He YQ; Li N; Cheng T; Sheng JQ
    PLoS One; 2017; 12(1):e0169124. PubMed ID: 28046028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.
    Chen D; Li Z; Cheng Q; Wang Y; Qian L; Gao J; Zhu JY
    J Clin Pathol; 2019 Sep; 72(9):588-596. PubMed ID: 31126975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
    Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
    Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
    Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
    Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.